Company: CERO
Filing Date: 2025-01-21
Form Type: 8-K
Source: 0001213900-25-004756
Chunk: 1

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: 8-K
Item: Item 8.01
Chunk 1
---
 and exercises of warrants to purchase shares of preferred stock since its last
balance sheet date of September 30, 2024, and has filed a registration statement under the Securities Act of 1933 for additional capital
raising intended to contribute materially to such stockholders’ equity. Nevertheless, the Company cannot assure its stockholders
that it will be successful in raising capital or in satisfying the minimum stockholders’ equity requirement by the Extension Date.

SIGNATURES

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

  Date: January 21, 2025      CERO THERAPEUTICS HOLDINGS, INC.                               
 ─────────────────────────────────────────────────────────────────────────────────────────────
                              By:                                   /s/ Chris Ehrlich        
                              Name:                                 Chris Ehrlich            
                              Title:                                Chief Executive Officer